+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Dissolvable Oral Thin Films Global Market Report 2023 - Product Thumbnail Image

Dissolvable Oral Thin Films Global Market Report 2023

  • Report
  • March 2023
  • 71 Pages
  • Global
Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • April 2025
  • 300 Pages
  • Global
From
Metastatic Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Alzheimer's Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 639 Pages
  • Global
From
Mantle Cell Lymphoma Therapeutics Market Report 2025 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 192 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 113 Pages
  • Global
From
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 383 Pages
  • Global
From
Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 78 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 93 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 231 Pages
  • Global
From
Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 228 Pages
  • Global
From
Drug Delivery Devices Market by Route of Administration, Vehicles, Application, End-user - Global Forecast 2025-2030 - Product Thumbnail Image

Drug Delivery Devices Market by Route of Administration, Vehicles, Application, End-user - Global Forecast 2025-2030

  • Report
  • October 2024
  • 194 Pages
  • Global
From
Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 109 Pages
  • Global
From
Loading Indicator